type here...

CATEGORIES

Healthcare

LATEST

1...202122...77Page 21 of 77

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

You Don’t Need to be an Idiot to be a CovIdiot

Medika Life -
The term CovIdiot is misleading as it suggests anti-vax and anti-pandemic people are idiots. Nothing could be further from the truth and this perception prevents us reaching this demographic.

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

Medika Life -
The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

FINN Adds Medika Life to its Omni-Channel Communications Platform

Medika Life -
FINN Partners adds Medika Life to it's Omni-Channel Health Platform, Gill Bashe to assume role of Editor in Chief as Medika strives to continue it founding goals.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories